Powered By
Seattle Genetics And Agensys, An Affiliate Of Astellas, Announce Initiation Of Phase I Clinical Trial Of ASG-5ME For ...
Published:Thu, 22 Jul 2010 05:29:11 -0700
Seattle Genetics, Inc. (Nasdaq:SGEN) and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors. There is significant need for new ......
del.icio.us
| 
Digg
| 
Reddit
|
More Articles
How to Increase Your Site Traffic and Succeed With Yo...Simple Steps For Newbies To Start In Affiliate Market...Affiliate Marketing...Internet Affiliate Programs – What Do You Need To S...Keys for a Successful Affiliate...Make Money Online With Affiliate Programs...Make More Money In Affiliate Marketing...Online Affiliate Program...Overview Of An Affiliate Marketing Program...Promoting your Affiliate Programs with Articles...When You Need A Good Dental Plan...Picking The Right Health Insurance Plan For You & You...Locating Excellent Humidifiers and Filters...More from Landmark Education Participants ...Free live chat software...Administrative Leadership and Language Translation Se...Various Jewelries and Accessories from Rothem Collect...Verizon wireless is right for your business...The diverse roles of sales and marketing executives ...Tips for Marketing Online to Specific Demography...Marketing Recruitment: Changing Perceptions with Evid...Satisfaction Guaranteed...